Items where authors include "Ford, H.L."

Article

Chataway, J., Williams, T., Blackstone, J. et al. (135 more authors) (2025) Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet, 406 (10512). pp. 1611-1624. ISSN 0140-6736

Horne, R.M., Hollomotz, A. orcid.org/0000-0003-3496-3924, Ford, H.L. et al. (5 more authors) (2025) Reader Response: Right Brain: The Unraveling. Neurology, 104 (7). e209834. ISSN 0028-3878

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

Fernandes, L., Coats, R.O. orcid.org/0000-0003-4415-408X, Mon-Williams, M. orcid.org/0000-0001-7595-8545 et al. (3 more authors) (2024) A novel tool for characterising upper limb function in progressive multiple sclerosis through kinematic assessment. Journal of the Neurological Sciences, 462. 123068. ISSN 0022-510X

Burton, L.E. orcid.org/0000-0002-4020-4249, Haywood, A.M. orcid.org/0000-0001-7008-0534, Tindall, J.C. et al. (5 more authors) (2024) The role of atmospheric CO2 in controlling sea surface temperature change during the Pliocene. Climate of the Past, 20 (5). pp. 1177-1194. ISSN 1814-9324

Giovannoni, G., Ford, H.L., Schmierer, K. et al. (12 more authors) (2024) MS care: integrating advanced therapies and holistic management. Frontiers in Neurology, 14. 1286122. ISSN 1664-2295

Yang, J., Antin, P., Berx, G. et al. (44 more authors) (2020) Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology, 21 (6). pp. 341-352. ISSN 1471-0072